AbbVie Investors Sue Over 1-Day $100M Stock Drop
A proposed class of AbbVie Inc. investors filed a stock drop suit against the pharmaceutical company in Illinois federal court Thursday, saying a corrective disclosure related to the company’s May stock buyback efforts led to a collective $100 million loss in value for the shareholders.